Mode
Text Size
Log in / Sign up

Cell surface glycoRNAs engage immune receptors, influencing neutrophil trafficking and immune activationGlycoRNAs Guide Immune Cells and May Shape Inflammation

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider glycoRNA-immune receptor interactions as emerging players in neutrophil trafficking and immune modulation, but await clinical validation.

This mini-review summarizes current understanding of cell surface glycoRNAs, a recently identified class of glycosylated RNAs, and their role in immune regulation. The authors synthesize findings from multiple studies to describe how these molecules interact with various immune receptor families, including P-selectin, Siglecs, Toll-like receptors (TLRs), and lectins. These interactions are implicated in key immune processes such as neutrophil trafficking, immune activation, and tolerance.

The review highlights that glycoRNA engagement with P-selectin is specifically linked to neutrophil recruitment, suggesting a potential mechanism for directing immune cells to sites of inflammation. Additionally, interactions with Siglecs and TLRs may modulate immune activation and tolerance, though the review does not provide quantitative effect sizes or primary data.

As a mini-review, this article serves as a narrative synthesis rather than a systematic quantitative analysis. The authors do not report a systematic search strategy, pooled effect estimates, or formal quality assessments. Limitations are not explicitly stated, and the review does not include primary clinical trial data.

For clinicians, this review offers foundational insights into a novel molecular pathway that may eventually inform therapeutic strategies targeting immune regulation. However, the findings are preliminary and mechanistic, with no direct clinical applications yet. Further research is needed to translate these observations into clinical practice.

This review looks at glycoRNAs, a type of RNA found on the outside of cells. These molecules are not just floating around; they interact with specific proteins on immune cells. The review gathers findings from many studies to show how glycoRNAs help immune cells do their jobs.

One key finding is that glycoRNAs can bind to several families of immune receptors. These include P-selectin, Siglecs, Toll-like receptors (TLRs), and lectins. Each of these receptors has a different role in the immune system. For example, P-selectin is important for helping white blood cells stick to blood vessel walls.

The review highlights that glycoRNAs are involved in neutrophil trafficking. Neutrophils are a type of white blood cell that fights infection. By interacting with P-selectin, glycoRNAs help neutrophils move to where they are needed, like sites of injury or infection.

GlycoRNAs also play a part in immune activation and tolerance. This means they can help turn on immune responses when needed, but also help calm them down to prevent damage. This balance is crucial for keeping the body healthy.

Overall, this review suggests that glycoRNAs are important players in the immune system. They help guide immune cells and influence how the body responds to threats. However, this is a summary of current knowledge, not a clinical trial. More research is needed to fully understand how glycoRNAs work and if they could be targets for new treatments.

What this means for you:
GlycoRNAs help guide immune cells and may influence inflammation, but more research is needed.

Common questions

What are glycoRNAs?

GlycoRNAs are RNA molecules that have sugar molecules attached to them. They are found on the surface of cells. This review suggests they may play a role in how the immune system responds, by interacting with certain receptors on immune cells.

How might glycoRNAs affect the immune system?

According to the review, glycoRNAs can interact with several immune receptor families, including P-selectin, Siglecs, Toll-like receptors, and lectins. One interaction, with P-selectin, appears to be involved in recruiting neutrophils, which are white blood cells that help fight infection.

Is this a proven treatment for immune conditions?

No. This is a review of existing research, not a clinical trial. It summarizes what is currently known about glycoRNAs and immune interactions. There is no evidence yet that this can be used to treat any condition. More research is needed.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Cell surface glycoRNAs have recently emerged as an unexpected class of RNA-glycan conjugates. Their discovery challenges the long-standing view that RNA is confined to intracellular compartments. These small noncoding RNAs, modified with N- or O-linked glycans and displayed on the outer leaflet of the plasma membrane, create a unique molecular interface recognizable by both glycan-binding and nucleic acid-sensing immune receptors. Recent studies suggest that glycoRNAs engage multiple immune receptor families, including P-selectin, Siglecs, Toll-like receptors (TLRs), and lectins, to influence neutrophil trafficking, immune activation, and tolerance. For instance, interactions between P-selectin and glycoRNAs have been implicated in neutrophil recruitment. In this Mini-Review, we summarize current knowledge of the molecular features of glycoRNAs and their emerging interfaces with immune receptors and discuss how glycoRNAs may represent a new layer of immune regulation at the cell surface.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.